Published in
Elsevier, Leukemia Research, (88), p. 106272, 2020
DOI: 10.1016/j.leukres.2019.106272
Links
Tools
A phase I study of panobinostat and ruxolitinib in patients with primary myelofibrosis (PMF) and post-polycythemia vera/essential thrombocythemia myelofibrosis (post-PV/ET MF)
Journal article published in 2020 by
J. Mascarenhas 
,
B. K. Marcellino ,
M. Lu,
M. Kremyanskaya,
F. Fabris,
L. Sandy,
M. Mehrotra,
J. Houldsworth,
V. Najfeld,
S. El Jamal ,
B. Petersen,
E. Moshier,
R. Hoffman
,
B. K. Marcellino ,
M. Lu,
M. Kremyanskaya,
F. Fabris,
L. Sandy,
M. Mehrotra,
J. Houldsworth,
V. Najfeld,
S. El Jamal ,
B. Petersen,
E. Moshier,
R. Hoffman
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 